The Commercialization of Clinical Genetics: An Analysis of Interrelations Between Academic Centers and For‐Profit Clinical Genetics Diagnostics Companies

The field of clinical genetics has undergone substantial commercialization, including the development of genetics diagnostics companies. Numerous for‐profit corporations now offer genetic diagnostic services; until recently, these clinical services were provided almost exclusively through academic, not‐for‐profit medical centers. Some of these for‐profit corporations have business and/or research relationships with academia. An evaluation of the interconnections between academia and the clinical genetics industry is an important first step in analyzing the risks and benefits of commercialization. We analyzed the personnel and business affiliations of 19 major U.S. for‐profit clinical genetics diagnostics companies with universities, academic medical centers, and the scientific and medical genetics communities in a 2‐year period, 1991–1992. We noted extensive connections between the for‐profit sector and academia. At least 17% of high‐ranking personnel and 85% of consultants for the companies had one or more academic ties. At least 68% of the companies had one or more business agreements with at least one university or academic medical center. These results raise many issues regarding the delivery of genetic medicine and the structure and function of academic medical genetics centers.